Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

452
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

528
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

621
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regression.

Metabolism: clinical and experimental·2026
Same author

AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical Trial.

JAMA cardiology·2026
Same author

A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and Regression.

bioRxiv : the preprint server for biology·2026
Same author

Developing the H-5, a Quantifiable Spiritual Assessment for Hospice Care.

The American journal of hospice & palliative care·2026
Same author

Lipoxins Regulate Intercalated Disk-Associated Signaling and Immune Remodeling in Dilated Cardiomyopathy.

bioRxiv : the preprint server for biology·2026
Same author

Emotional intelligence and counseling self-efficacy among clinical pastoral education students in a multicenter sample: a baseline analysis.

Journal of health care chaplaincy·2026
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026
查看所有相关文章

相关实验视频

Updated: May 7, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.7K

美国心脏协会/美国中风协会的政策声明

Lynne T Braun, Kathleen L Grady, Jean S Kutner

    Circulation
    |August 10, 2016
    PubMed
    概括
    此摘要是机器生成的。

    对于晚期心血管疾病和中风患者,应及早整合息治疗,以改善生活质量. 政策建议侧重于补偿,护理模式,系统政策和医疗专业教育.

    关键词:
    AHA的科学声明缓解性护理生活质量治疗结果

    更多相关视频

    Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
    04:03

    Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

    Published on: February 21, 2025

    1.3K
    Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
    08:56

    Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

    Published on: October 10, 2025

    829

    相关实验视频

    Last Updated: May 7, 2026

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.7K
    Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
    04:03

    Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

    Published on: February 21, 2025

    1.3K
    Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
    08:56

    Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

    Published on: October 10, 2025

    829

    科学领域:

    • 心脏病学
    • 神经学
    • 缓和护理

    背景情况:

    • 美国心脏协会/美国中风协会的使命是强调高质量的,与患者价值观一致的基于证据的护理.
    • 通过对患者和家属的痛苦进行管理,
    • 在晚期心血管疾病和中风中早期整合缓解护理至关重要.

    研究的目的:

    • 为高级心血管疾病和中风患者提供缓解护理的重要性提供背景信息.
    • 为将息治疗纳入标准治疗做出政策建议.

    主要方法:

    • 根据现有证据和专家共识制定政策声明.
    • 分析目前的护理缺口和提供息护理的潜在解决方案.
    • 制定有关报销,付款人与提供者关系,医疗保健系统和教育的建议.

    主要成果:

    • 息治疗应该以患者和家人为中心, 解决身体,情感,精神和心理上的痛苦.
    • 政策的关键领域包括报销,数据共享,改善的护理/支付模式和质量标准.
    • 医疗保健系统需要在住院和护理过渡期间制定综合性息护理政策.
    • 医疗保健专业人员在息护理方面的教育是建议获得许可的.

    结论:

    • 整合息护理对于改善结果和与以患者为中心的护理目标保持一致至关重要.
    • 需要改变政策以确保心血管和中风患者获得全面的息护理.
    • 加强教育和系统支持对于有效提供息护理至关重要.